❓ Why is addressing the burden of unnecessary cytoscopies in patients with #microhematuria important? 📺 Dr. Yair Lotan of UT Southwestern Urology discusses the STRATA trial on reducing unnecessary cystoscopies in this patient population with the Cxbladder Triage: buff.ly/3WhPhDU

Can We Be Less Active in Prostate Cancer Surveillance? read the full article here! 👉 bit.ly/4j0I4SF #AUA #Urology #AUAmembers #TheVoiceofUrology

Shocking stats reveal that 1 in 4 Black men will be diagnosed with prostate cancer? 🧑🏿‍⚕️   🔗 Check your risk: prostatecanceruk.org/risk-checker   🔍Read more: urologynews.uk.com/news/post/pros…   #urologynews Prostate Cancer UK

Check out the February issue of JU today! 📰 Read the articles here ➡️ bit.ly/40cvh78 #TheVoiceOfUrology #AUA #AUAMembers #Urology

Johnson & Johnson has initiated the submission of a new drug application with the FDA to support regulatory approval of TAR-200 for patients with BCG-unresponsive high-risk NMIBC. #blcsm urologytimes.com/view/new-drug-…

New year, new opportunities! Our growing practice is looking for dedicated professionals to join our dynamic team. We're currently looking for a Clinical Research Compliance Specialist, among other positions. Learn more and apply: paycomonline.net/v4/ats/web.php…

Annual Meeting is just around the corner, and we’re counting down the days to reconnect with the urological community in vibrant Las Vegas! 🎉 📍 Where: Las Vegas, NV 📅 When: April 26–29, 2025 (Saturday–Tuesday) Get ready for an unforgettable experience filled with innovation,

New NCCN Patient Resource Shares Latest Understanding of Genetic Testing to Guide Patient Decision Making. Learn more: nccn.org/home/news/news…

A new ultrasound imaging technique from Heriot-Watt University shows a staggering 94% sensitivity rate in detecting #ProstateCancer! This could change the game for early diagnosis.💡   👇Learn more: urologynews.uk.com/news/post/new-… #urologynews Heriot-Watt University Less Grey Imaging

Findings from a recent study suggest that the addition of PSMA PET to conventional imaging-based assessments may lead to significant stage migration in patients with mHSPC. #pcsm urologytimes.com/view/addition-…

🧬 Metastatic castration-resistant #prostatecancer is commonly linked to several tumor gene mutations. 🔬 A recent study analyzed and compared PFS and OS rates among patients with mCRPC who harbored tumor suppressor gene mutations such as TP53 and PTEN: buff.ly/40CJgEo

“If patients are not experiencing a clear clinical benefit for chemotherapy prior to surgery, we need to be really thoughtful about how we use it,” says Fed Ghali, MD. Fed Ghali Yale Urology urologytimes.com/view/challenge…

#Medicare Part D changes reduce out-of-pocket costs for #ProstateCancer patients. David Morris, MD, FACS Urology Associates sits with Ruchika Talwar Vanderbilt Urology to discuss changes to Medicare Part D resulting from the Inflation Reduction Act > bit.ly/3MQDJ5s

ASCO #GU25 is almost here! Join world-renowned experts in the field as they demonstrate how to apply the newest innovations in patient-centered care to your clinical practice.

For anyone who did not match and is interested in doing a research year instead of a prelim year, please consider applying for our Steers research fellowship.

PSMA PET imaging and targeted therapies: a case study on high-risk localized #ProstateCancer. Tian Zhang, MD, MHS @UTSWNews and Elena Castro discuss in this Independent Medical Education Initiative on UroToday > bit.ly/3IdC7Rd Bayer | Pharmaceuticals

🧵 Many “hot takes” about the reduction of NIH indirect grant costs to 15%. Let’s lay out the facts about the university grant management process & accounting. And then use this to project likely short and longer term impacts of the policy.

Genomic classifier #Decipher® guides treatment intensification in post-prostatectomy patients. Phuoc T. Tran University of Maryland School of Medicine joins Angela Jia RadOncUH to discuss findings from the RTOG 0534 #SPPORT trial examining the Decipher® genomic classifier scores as predictors of treatment

A 💝-to-💝 message from Chesapeake Urology: Taking good care of yourself is the best gift you can give your loved ones. If you're living with difficult urological symptoms, we're here to support you.

The highlight of #ASCO25 was the AMPLITUDE trial presented by AttardLab on PARPi in HRR altered mHSPC. Listen to our podcast discussing these practice-changing data! spotifycreators-web.app.link/e/77hbNX73YTb